Therapeutic Advances in Drug Safety

443 papers and 9.9k indexed citations i.

About

The 443 papers published in Therapeutic Advances in Drug Safety in the last decades have received a total of 9.9k indexed citations. Papers published in Therapeutic Advances in Drug Safety usually cover Geriatrics and Gerontology (115 papers), Toxicology (78 papers) and Cardiology and Cardiovascular Medicine (75 papers) specifically the topics of Pharmaceutical Practices and Patient Outcomes (114 papers), Pharmacovigilance and Adverse Drug Reactions (76 papers) and Pharmaceutical studies and practices (55 papers). The most active scholars publishing in Therapeutic Advances in Drug Safety are Carl Llor, Lars Bjerrum, Riccardo Polosa, Konstantinos Farsalinos, Paul Gallagher, Joel J. Heidelbaugh, Amanda Lavan, Daniel P. Wermeling, Cory Toth and Jeffrey L. Galinkin.

In The Last Decade

Fields of papers published in Therapeutic Advances in Drug Safety

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Therapeutic Advances in Drug Safety. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Therapeutic Advances in Drug Safety.

Countries where authors publish in Therapeutic Advances in Drug Safety

Since Specialization
Citations

This map shows the geographic impact of research published in Therapeutic Advances in Drug Safety. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Therapeutic Advances in Drug Safety with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therapeutic Advances in Drug Safety more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025